Discovery and validation of prognostic markers in gastric cancer by genome-wide expression profiling

查看全文 作　　者：Yue-Zheng [1,2,3]Zhang;Lian-Hai [4]Zhang;Yang [1,2]Gao;Chao-Hua [1,2]Li;Shu-[4]Qinjia;Ni [3]Liu;Feng [1,2]Cheng;De-Yun [1,2,3]Niu;William CS [5]Cho;Jia-Fu [3]Ji;Chang-Qing [1,6]Zeng

机构地区：[1]Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100029, China;[2]CAS Key Laboratory of Genome Sciences andInformation, Chinese Academy of Sciences, Beijing Institute ofGenomics, Beijing 100029, China;[3]Graduate School of ChineseAcademy of Sciences, Beijing 100049, China;[4]Key Labora-tory of Carcinogenesis and Translational Research (Ministry ofEducation), Department of Surgery, Beijing Cancer Hospitaland Institute, Peking University School of Oncology, Beijing100142, China;[5]Department of Clinical Oncology, QueenElizabeth Hospital, Hong Kong, China;[6]Laboratory of Cancer Genomics and Personalized Medicine, Beijing Institute of Genomics, ChineseAcademy of Sciences, Beijing 100029, China

出　　处：《World Journal of Gastroenterology》索引2011年第17卷第13期,共8页

基　　金：Supported by the National 863 Program (SQ2009AA02-XK1482570 and 2006AA02A402);Beijing Municipal Committeeof Science and Technology (D0905001040631) ;Beijing Capi-tal Development Foundation of Health Bureau (2007-2051) 摘　　要：AIM: To develop a prognostic gene set that can predict patient overall survival status based on the whole genome expression analysis. METHODS: Using Illumina HumanWG-6 BeadChip followed by semi-supervised analysis, we analyzed the expression of 47 296 transcripts in two batches of gastric cancer patients who underwent surgical resection. Thirty-nine samples in the first batch were used as the training set to discover candidate markers correlated to overall survival, and thirty-three samples in the second batch were used for validation. RESULTS: A panel of ten genes were identified as prognostic marker in the first batch samples and classified patients into a lowand a high-risk group with significantly different survival times (P = 0.000047). This prognostic marker was then verified in an independent validation sample batch (P = 0.0009). By comparing with the traditional Tumor-node-metastasis (TNM) staging system, this ten-gene prognostic marker showed consistent prognosis results. It was the only independent prognostic value by multivariate Cox regression analysis (P = 0.007). Interestingly, six of these ten genes are ribosomal proteins, suggesting a possible association between the deregulation of ribosome related gene expression and the poor prognosis. CONCLUSION: A ten-gene marker correlated with overall prognosis, including 6 ribosomal proteins, was identified and verified, which may complement the predictive value of TNM staging system. 关键词：全基因组预后验证胃癌表达谱标志物核糖体蛋白基因标记

相关文献

参考文献（29）
引证文献（5）
耦合文献（0）

参考文献(29)

引证文献(5)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Discovery and validation of prognostic markers in gastric cancer by genome-wide expression profiling

参考文献(29)

引证文献(5)

用户提示